Cortexyme, Inc. (16)
Browse by Contract Category
Contracts
-
Description of Securities
(Filed With SEC on March 1, 2021)
-
Separation Agreement by and between Kristen Gafric and Cortexyme, Inc., dated as of April 27, 2020
(Filed With SEC on August 14, 2020)
-
Form of Stock Purchase Agreement
(Filed With SEC on February 6, 2020)
-
Form of Indemnification Agreement between Cortexyme, Inc. and each of its officers and directors
(Filed With SEC on April 29, 2019)
-
Second Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated May 26, 2020
(Filed With SEC on August 14, 2020)
-
Form of Executive Change in Control and Severance Agreement
(Filed With SEC on May 21, 2020)
-
Description of Securities
(Filed With SEC on March 16, 2020)
-
Amendment No. 1 to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated April 2, 2019
(Filed With SEC on August 9, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on April 29, 2019)
-
Specimen Stock Certificate
(Filed With SEC on April 29, 2019)
-
2019 Equity Incentive Plan and forms of stock award agreements thereunder
(Filed With SEC on April 29, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on April 29, 2019)
-
Amended and Restated Investors Rights Agreement by and among Cortexyme, Inc. and certain holders of its capital stock, dated May 23, 2018
(Filed With SEC on April 12, 2019)
-
Sub-Sublease Agreement by and between Cortexyme, Inc. and Verily Life Sciences LLC, dated June 18, 2018
(Filed With SEC on April 12, 2019)
-
2014 Stock Plan, as amended as of November 28, 2018, and related forms of stock award agreements
(Filed With SEC on April 12, 2019)
-
Executive Incentive Bonus Plan
(Filed With SEC on April 12, 2019)